🔎 Trials Near Me

መነሻ › የሜታቦሊክ ህመሞች › Texas

በTexas ለየሜታቦሊክ ህመሞች የሚደረጉ ክሊኒካዊ ጥናቶች

ለየሜታቦሊክ ህመሞች የሚደረጉ 7 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
  • VIP Trials, San Antonio
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07595549

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Amarillo
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • እና 30 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Amarillo
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • እና 21 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06419374

Genetic and Metabolic Disease in Children

  • Children's Medical Center at Dallas, Dallas
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
1 Day · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT02650622

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

  • Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ማርች 2026 · NCT05130437

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጃንዩ 2026 · NCT04159103

Rare and Atypical Diabetes Network

  • Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2025 · NCT05544266

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።